NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Rand A Alattar
Hamad Medical Corporation - Doha / Qatar
Others
AD Scientific Index ID: 4698750
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Rand A Alattar's MOST POPULAR ARTICLES
1-)
Tocilizumab for the treatment of severe coronavirus disease 2019 Journal of medical virology 92 (10), 2042-2049, 2020
2-)
The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study BMC infectious diseases 20, 1-11, 2020
3-)
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: a preliminary report Journal of Medical Virology 93 (3), 1678-1686, 2021
4-)
The First Consecutive 5000 Patients with COVID-19 in Qatar; a Nation-wide Cohort Study medRxiv, 2020.07. 15.20154690, 2020
5-)
Tocilizumab for the treatment of severe COVID-19. J Med VirolR Alattar, TBH Ibrahim, SH Shaar22020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept